company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44008000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44008000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30246000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30246000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13762000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5643000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,8565000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3202000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3632000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21042000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7280000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1148000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,330000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-818000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8098000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,158000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8256000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8256000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8256000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48600000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48600000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47492000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:52:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,45033000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,45033000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30073000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30073000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14960000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6023000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,8452000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3132000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3788000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21395000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6435000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1176000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-341000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1517000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7952000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,212000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8164000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8164000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8164000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48000000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48000000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48049000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:18:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50564000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50564000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32531000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32531000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18033000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5582000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,9210000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3717000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4158000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22667000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4634000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1157000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-26000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1183000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5817000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,193000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6010000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6010000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6010000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54600000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54600000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53423000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 11:21:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53768000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53768000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34903000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34903000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18865000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5460000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,9369000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3589000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4431000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22849000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3984000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1170000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-170000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1340000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5324000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,226000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5550000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5550000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5550000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55500000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55500000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54014000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 14:13:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,55903000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,55903000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,36363000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,36363000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19540000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5708000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,9446000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3388000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4709000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23251000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3711000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1186000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-146000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1332000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5043000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,235000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5278000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5278000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5278000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52800000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52800000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54428000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:29:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57021000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57021000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,35851000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,35851000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21170000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6456000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,9525000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3743000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4618000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24342000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3172000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1201000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,54000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1147000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4319000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,245000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4564000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4564000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4564000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54900000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54900000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54217000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56951000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56951000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,35639000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,35639000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21312000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6622000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,9920000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3897000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4532000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24971000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3659000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1193000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-52000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1245000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4904000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,240000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5144000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5144000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5144000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57200000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57200000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55773000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q1,2012-01-01,2012-03-31,2013-05-02 10:14:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59009000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59009000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,36620000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,36620000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22389000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6930000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,9918000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4250000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4582000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25680000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3291000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1456000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-79000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1535000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4826000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,237000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5063000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5063000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5063000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56300000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56300000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57733000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 10:14:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,61152000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,61152000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,37404000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,37404000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23748000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6921000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,10168000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4274000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4731000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26094000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2346000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,26000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,13000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2359000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,223000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2582000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2582000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2582000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64600000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64600000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58945000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 09:00:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,65020000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,65020000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39661000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39661000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25359000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7057000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,10479000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4690000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5043000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27269000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1910000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2675000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2766000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-30000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-121000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2031000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,333000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2364000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2364000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2364000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58300000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58300000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57890000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,61644000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,61644000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,37644000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,37644000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24000000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7824000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,10696000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5108000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4908000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28536000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4536000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,150000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-176000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-326000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4862000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,132000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4994000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4994000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4994000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62400000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62400000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59381000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:55:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,65462000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,65462000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,40375000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,40375000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25087000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8239000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,11716000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4366000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5037000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29358000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4271000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-150000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-160000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4431000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1026000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3405000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3405000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3405000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56800000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56800000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60036000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 07:54:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,66873000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,66873000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,41345000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,41345000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25528000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7791000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,12374000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4450000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5326000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29941000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4413000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-162000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-142000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-304000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4717000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,269000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4986000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4986000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4986000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62300000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62300000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60675000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:16:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,69450000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,69450000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,41562000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,41562000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27888000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8472000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,13056000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4963000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5975000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32466000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4578000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-150000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-299000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-69000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-218000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4796000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,380000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5176000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5176000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5176000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59900000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59900000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60261000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,72221000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,72221000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43287000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43287000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28934000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8821000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,13218000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5134000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6550000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33723000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4789000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-198000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,23000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-175000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4964000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,346000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5310000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5310000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-35000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5275000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58600000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58600000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61252000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:46:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,74083000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,74083000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46553000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46553000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27530000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8399000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,13589000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5708000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6485000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34181000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6651000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-195000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-212000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6863000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,332000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7195000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7195000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-82000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7113000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59300000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59300000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61469000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 10:09:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,75286000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,75286000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46699000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46699000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28587000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8379000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,13873000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6182000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6427000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34861000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6274000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-255000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-265000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6539000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,295000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6834000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6834000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-128000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6706000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61000000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61000000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61804000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 18:03:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,79911000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,79911000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,49059000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,49059000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30852000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8470000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14705000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5611000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6539000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35325000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4473000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-215000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-221000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4694000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,280000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4974000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4974000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-122000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4852000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61400000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61400000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61700000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,79482000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,79482000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,49356000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,49356000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30126000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8912000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14548000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5874000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6371000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35705000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5579000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-241000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,264000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,23000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5556000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,307000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5863000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5863000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-205000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5658000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62900000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62900000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62836000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:07:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,80316000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,80316000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,49452000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,49452000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30864000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8585000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14518000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6622000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6255000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35980000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5116000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-242000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,37000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-205000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5321000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,273000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5594000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5594000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-267000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5327000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66600000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66600000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63288000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:42:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,86521000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,86521000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,51803000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,51803000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34718000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8642000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14445000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6752000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6514000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36353000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1635000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-312000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,235000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-77000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1712000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,290000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2002000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2002000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-315000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1687000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56200000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56200000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63528000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:33:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89804000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89804000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,54041000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,54041000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35763000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8985000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15017000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6989000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,7071000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38062000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2299000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-320000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,25000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-295000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2594000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,207000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2801000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2801000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-131000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2670000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63900000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63900000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63384000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89207000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89207000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,52690000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,52690000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36517000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8031000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15254000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7154000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,7053000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37492000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-975000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-241000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-232000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-473000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1448000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,335000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1783000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1783000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-507000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1276000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63800000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63800000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64179000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:31:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,92207000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,92207000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,53784000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,53784000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38423000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8511000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16116000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7961000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,7015000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39603000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1180000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-288000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-409000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-697000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1877000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,348000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2225000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2225000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-493000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1732000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57700000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57700000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64428000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:14:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,91951000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,91951000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,52770000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,52770000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39181000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7792000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16024000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8278000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,7063000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39157000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,24000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-244000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-346000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-590000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-566000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,324000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-890000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-890000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-724000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-166000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64638000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64638000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64638000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 16:15:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,93013000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,93013000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,55149000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,55149000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,37864000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8447000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16484000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7639000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,7448000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40018000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2154000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-227000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,57000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-170000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2324000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,95000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2419000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2419000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-822000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1597000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68200000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68200000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64520000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,96829000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,96829000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,55639000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,55639000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41190000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8950000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16770000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9508000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,7643000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42871000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1681000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-203000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-270000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-473000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2154000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-613000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1541000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1541000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-352000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1189000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59500000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59500000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65275000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 12:31:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,96216000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,96216000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,55050000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,55050000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41166000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9668000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16841000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9027000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,7686000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43222000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2056000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-224000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-321000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-545000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2601000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-22000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2579000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2579000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-490000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2089000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69600000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69600000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65821000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 15:14:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,97295000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,97295000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,56688000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,56688000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40607000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12619000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16984000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11222000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,8065000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48890000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8283000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-168000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,26000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-142000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8425000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,469000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8894000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8894000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,481000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-449000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8926000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66082000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66082000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63800000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 16:48:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,103601000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,103601000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,58276000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,58276000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45325000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10576000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,17639000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9851000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,9090000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47156000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1831000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-161000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-298000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-459000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2290000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,21000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2311000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2311000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-42000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2269000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65800000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65800000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65856000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,107298000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,107298000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,61133000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,61133000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,46165000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10460000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,18055000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9438000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,9342000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47295000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1130000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-109000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-295000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-404000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1534000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,264000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1798000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1798000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-339000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1459000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73000000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73000000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66355000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 12:31:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,106970000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,106970000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,61023000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,61023000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45947000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9751000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,18131000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10593000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,8561000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47036000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1089000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-88000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-672000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-760000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1849000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,372000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2221000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2221000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,368000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2589000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64700000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64700000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66552000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q2,2018-04-01,2018-06-30,2018-08-07 15:14:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,108122000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,108122000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,61589000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,61589000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,46533000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9388000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,17549000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9698000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,8636000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45271000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1262000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-69000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,109000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,40000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1302000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,512000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,790000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,790000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,68000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-91000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,813000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66660000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68009000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,81300000.0
NxStage Medical Inc,NXTM,5493005XCGADLOHOEN63,0001333170,2018.0,Q3,2018-07-01,2018-09-30,2018-11-07 16:48:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
